Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-24 4:51 pm Purchase | 2024-06-14 | 13G | UROGEN PHARMA LTD URGN | Point72 Asset Management, L.P. | 2,569,826 6.200% | 2,569,826![]() (New Position) | Filing History |
| 2024-06-24 4:16 pm Purchase | 2024-06-21 | 13G | SPHERE ENTERTAINMENT CO. SPHR | Point72 Asset Management, L.P. | 1,560,170 5.500% | 1,560,170![]() (New Position) | Filing History |
| 2024-06-14 4:34 pm Purchase | 2024-06-04 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Point72 Asset Management, L.P. | 3,225,250 5.700% | 3,225,250![]() (New Position) | Filing History |
| 2024-06-10 4:29 pm Purchase | 2024-06-07 | 13G | MARAVAI LIFESCIENCES HLDGS INC MRVI | Point72 Asset Management, L.P. | 6,647,015 5.000% | 6,647,015![]() (New Position) | Filing History |
| 2024-05-21 4:56 pm Purchase | 2024-05-20 | 13G | RAPID7 INC RPD | Point72 Asset Management, L.P. | 3,121,415 5.000% | 1,243,804![]() (+66.24%) | Filing History |
| 2024-05-09 5:29 pm Purchase | 2024-05-02 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Point72 Asset Management, L.P. | 17,050,384 9.900% | 17,050,384![]() (New Position) | Filing History |
| 2024-04-26 4:15 pm Purchase | 2024-04-25 | 13G | AVID BIOSERVICES INC CDMO | Point72 Asset Management, L.P. | 3,226,006 5.100% | 3,226,006![]() (New Position) | Filing History |
| 2024-04-05 4:05 pm Purchase | 2024-04-04 | 13G | SUTRO BIOPHARMA INC STRO | Point72 Asset Management, L.P. | 593,291 7.900% | 593,291![]() (New Position) | Filing History |
| 2024-03-26 4:21 pm Purchase | 2024-03-25 | 13G | FOX CORP FOXA | Point72 Asset Management, L.P. | 12,046,118 5.000% | 12,046,118![]() (New Position) | Filing History |
| 2024-03-25 4:33 pm Purchase | 2024-03-21 | 13G | LENZ THERAPEUTICS INC LENZ | Point72 Asset Management, L.P. | 1,882,693 7.400% | 1,882,693![]() (New Position) | Filing History |
| 2024-03-07 4:15 pm Purchase | 2024-03-06 | 13G | TERNS PHARMACEUTICALS INC TERN | Point72 Asset Management, L.P. | 3,921,226 6.300% | 3,921,226![]() (New Position) | Filing History |
| 2024-02-29 4:31 pm Purchase | 2024-02-28 | 13G | PULMONX CORP LUNG | Point72 Asset Management, L.P. | 1,936,083 5.000% | 389,994![]() (+25.22%) | Filing History |
| 2024-02-27 4:14 pm Purchase | 2024-02-26 | 13G | LIBERTY MEDIA CORP DEL COM LIB LLYVA | Point72 Asset Management, L.P. | 1,287,149 5.000% | 1,287,149![]() (New Position) | Filing History |
| 2024-02-23 4:28 pm Purchase | 2024-02-22 | 13G | VENTYX BIOSCIENCES INC VTYX | Point72 Asset Management, L.P. | 3,017,093 5.100% | 3,017,093![]() (New Position) | Filing History |
| 2024-02-23 4:15 pm Purchase | 2024-02-22 | 13G | CARIBOU BIOSCIENCES INC CRBU | Point72 Asset Management, L.P. | 4,432,602 5.000% | 435,057![]() (+10.88%) | Filing History |
| 2024-02-21 4:16 pm Purchase | 2024-02-20 | 13G | AGENUS INC AGEN | Point72 Asset Management, L.P. | 1,413,425 6.800% | 1,413,368![]() (+2479592.98%) | Filing History |
| 2024-02-14 4:20 pm Purchase | 2023-12-31 | 13G | ABEONA THERAPEUTICS INC NE ABEO | Point72 Asset Management, L.P. | 1,649,740 6.400% | 499,092![]() (+43.37%) | Filing History |
| 2024-02-14 4:19 pm Purchase | 2023-12-31 | 13G | PAGSEGURO DIGITAL LTD PAGS | Point72 Asset Management, L.P. | 10,933,610 5.600% | 231,012![]() (+2.16%) | Filing History |
| 2024-02-14 4:18 pm Purchase | 2023-12-31 | 13G | LYRA THERAPEUTICS INC LYRA | Point72 Asset Management, L.P. | 60,606 5.800% | 606![]() (+1.01%) | Filing History |
| 2024-02-14 4:17 pm Sale | 2023-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Point72 Asset Management, L.P. | 2,756,122 5.000% | -866,014![]() (-23.91%) | Filing History |

